Literature DB >> 23648860

Effect of culture conditions and signal peptide on production of human recombinant N-acetylgalactosamine-6-sulfate sulfatase in Escherichia coli BL21.

Alejandra Hernández1, Olga Velásquez, Felice Leonardi, Carlos Soto, Alexander Rodríguez, Lina Lizaraso, Ángela Mosquera, Jorge Bohórquez, Alejandra Coronado, Ángela Espejo, Rocio Sierra, Oscar F Sánchez, Carlos J Alméciga-Díaz, Luis A Barrera.   

Abstract

The production and characterization of an active recombinant N-acetylgalactosamine-6-sulfate sulfatase (GALNS) in Escherichia coli BL21(DE3) has been previously reported. In this study, the effect of the signal peptide (SP), inducer concentration, process scale, and operational mode (batch and semi-continuous) on GALNS production were evaluated. When native SP was presented, higher enzyme activity levels were observed in both soluble and inclusion bodies fractions, and its removal had a significant impact on enzyme activation. At shake scale, the optimal IPTG concentrations were 0.5 and 1.5 mM for the strains with and without SP, respectively, whereas at bench scale, the highest enzyme activities were observed with 1.5 mM IPTG for both strains. Noteworthy, enzyme activity in the culture media was only detected when SP was presented and the culture was carried out under semi-continuous mode. We showed for the first time that the mechanism that in prokaryotes recognizes the SP to mediate sulfatase activation can also recognize a eukaryotic SP, favoring the activation of the enzyme, and could also favor the secretion of the recombinant protein. These results offer significant information for scaling-up the production of human sulfatases in E. coli.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23648860     DOI: 10.4014/jmb.1211.11044

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  5 in total

Review 1.  Mucopolysaccharidosis IVA and glycosaminoglycans.

Authors:  Shaukat Khan; Carlos J Alméciga-Díaz; Kazuki Sawamoto; William G Mackenzie; Mary C Theroux; Christian Pizarro; Robert W Mason; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-11-29       Impact factor: 4.797

Review 2.  Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.

Authors:  Shunji Tomatsu; Kazuki Sawamoto; Carlos J Alméciga-Díaz; Tsutomu Shimada; Michael B Bober; Yasutsugu Chinen; Hiromasa Yabe; Adriana M Montaño; Roberto Giugliani; Francyne Kubaski; Eriko Yasuda; Alexander Rodríguez-López; Angela J Espejo-Mojica; Oscar F Sánchez; Robert W Mason; Luis A Barrera; William G Mackenzie; Tadao Orii
Journal:  Drug Des Devel Ther       Date:  2015-04-01       Impact factor: 4.162

Review 3.  Research, diagnosis and education in inborn errors of metabolism in Colombia: 20 years' experience from a reference center.

Authors:  Olga Y Echeverri; Johana M Guevara; Ángela J Espejo-Mojica; Andrea Ardila; Ninna Pulido; Magda Reyes; Alexander Rodriguez-Lopez; Carlos J Alméciga-Díaz; Luis A Barrera
Journal:  Orphanet J Rare Dis       Date:  2018-08-16       Impact factor: 4.123

4.  Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris.

Authors:  Alexander Rodríguez-López; Carlos J Alméciga-Díaz; Jhonnathan Sánchez; Jefferson Moreno; Laura Beltran; Dennis Díaz; Andrea Pardo; Aura María Ramírez; Angela J Espejo-Mojica; Luisa Pimentel; Luis A Barrera
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

5.  Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches.

Authors:  Luis H Reyes; Carolina Cardona; Luisa Pimentel; Alexander Rodríguez-López; Carlos J Alméciga-Díaz
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.